Maximum Dose of Buspar (Buspirone)
The maximum recommended dose of Buspar (buspirone) is 60 mg per day, typically administered as 20 mg three times daily 1, 2.
Dosing Algorithm
Standard Dosing for Anxiety
- Initial dose: 5 mg twice daily (10 mg/day total)
- Titration: Increase by 5 mg/day every 2-3 days as tolerated
- Target dose: 15-30 mg/day in divided doses (typically twice or three times daily)
- Maximum dose: 60 mg/day (20 mg three times daily)
The FDA label confirms that clinical trials used doses up to 60 mg/day for generalized anxiety disorder 2. While one overdose study documented doses as high as 375 mg/day in healthy volunteers (resulting in nausea, vomiting, dizziness, drowsiness, and miosis), this far exceeds therapeutic dosing and is not recommended for clinical practice 2.
Special Population Considerations
Elderly Patients (Alzheimer's/Dementia)
Guidelines for managing agitation in Alzheimer's disease recommend a more conservative maximum of 60 mg/day (20 mg three times daily), though they note buspirone is useful only for mild to moderate agitation and may take 2-4 weeks to become effective 1.
Pediatric Patients
In children and adolescents (ages 6-17), studies evaluated doses of 15-60 mg/day (7.5-30 mg twice daily), though efficacy was not superior to placebo for generalized anxiety disorder at these doses 2. Pharmacokinetic data show higher plasma concentrations in children compared to adults at equivalent doses, suggesting caution with dose escalation 3.
Hepatic or Renal Impairment
Buspirone should be avoided in severe hepatic or renal impairment due to increased plasma levels and prolonged half-life 2. If used in moderate impairment, doses should be reduced significantly below the standard maximum.
Clinical Context from Research
Depression studies used flexible dosing up to 90 mg/day, with the most frequently effective dose being 40 mg/day 4, 5, 6. However, these higher doses are not FDA-approved and should only be considered under specialist guidance for treatment-resistant cases.
Critical Warnings
- Onset of action: 2-4 weeks required for full anxiolytic effect 1
- CYP3A4 interactions: Potent inhibitors (ketoconazole, ritonavir) require dose reduction; inducers (carbamazepine, phenytoin) may require dose increase 2
- Not for acute anxiety: Buspirone lacks immediate anxiolytic effects and is inappropriate for as-needed use
- Discontinue 48 hours before catecholamine testing: Can cause false-positive results for pheochromocytoma 2